Akorn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AKORN, and what generic and branded alternatives to AKORN drugs are available?
AKORN has thirty-two approved drugs.
There are two tentative approvals on AKORN drugs.
Summary for Akorn
US Patents: | 0 |
Tradenames: | 28 |
Ingredients: | 28 |
NDAs: | 32 |
Patent Litigation for Akorn: | See patent lawsuits for Akorn |
PTAB Cases with Akorn as petitioner: | See PTAB cases with Akorn as petitioner |
Drugs and US Patents for Akorn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akorn | NEMBUTAL | pentobarbital sodium | SUPPOSITORY;RECTAL | 083247-002 | Jan 25, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Akorn | AZELASTINE HYDROCHLORIDE | azelastine hydrochloride | SPRAY, METERED;NASAL | 210032-001 | Aug 23, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Akorn | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | SPRAY;TOPICAL | 207094-001 | Dec 7, 2016 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.